Vitality Watch

Dossier clinicaltrials trial early 12-aug-2026
Small or early-phase human trial or pilot study

The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health

Key claim: A 12-week randomized placebo-controlled trial will test whether Quercefit® (quercetin phytosome, 500 mg/day) or Ubiqsome™ (CoQ10 phytosome, 300 mg/day) improve blood sugar, cholesterol, inflammation-related aging markers, grip strength, fatigue, and quality of life in older adults.

Abstract

The goal of this clinical trial is to learn if Quercefit® or Ubiqsome™ can improve markers of healthy aging, blood sugar control, and heart health in older adults. It will also learn about the safety of these supplements.

The main questions it aims to answer are:

  1. Do Quercefit® or Ubiqsome™ improve blood sugar, cholesterol, and markers of aging compared to a placebo?
  2. What side effects, if any, do participants have while taking these supplements?

Researchers will compare Quercefit® (500 mg/day), Ubiqsome™ (300 mg/day), and a placebo (a look-alike capsule with no active ingredient).

Participants will:

  1. Take their assigned capsules (Quercefit®, Ubiqsome™, or placebo) twice daily for 12 weeks

  2. Go to a preferred clinic at the start and end of the study for a fasting blood draw

    Complete at-home tests:

  3. Grip strength testing (using a device mailed to them)

  4. Online surveys about fatigue and quality of life

  5. Report any side effects and keep track of supplement use

Why this matters

A 12-week randomized placebo-controlled trial will test whether Quercefit® (quercetin phytosome, 500 mg/day) or Ubiqsome™ (CoQ10 phytosome, 300 mg/day) improve blood sugar, cholesterol, inflammation-related aging markers, grip strength, fatigue, and quality of life in older adults.

Source

Link

Briefing card

The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health
Stage: trial early · clinicaltrials · 12-aug-2026

A 12-week randomized placebo-controlled trial will test whether Quercefit® (quercetin phytosome, 500 mg/day) or Ubiqsome™ (CoQ10 phytosome, 300 mg/day) improve blood sugar, cholesterol, inflammation-related aging markers, grip strength, fatigue, and quality of life in older adults.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07760506

build build 880 · 2bcef25 · 2026-11-18